Total Valuation
Organigram Global has a market cap or net worth of $169.94M. The enterprise value is $217.07.
Market Cap$169.94M
Enterprise Value$217.07
Share Statistics
Organigram Global has 141,006,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding141,006,500
Owned by Insiders35.22%
Owned by Institutions1.22%
Financial Efficiency
Organigram Global’s return on equity (ROE) is -0.07 and return on invested capital (ROIC) is -12.98%.
Return on Equity (ROE)-0.07
Return on Assets (ROA)-0.04
Return on Invested Capital (ROIC)-12.98%
Return on Capital Employed (ROCE)-0.20
Revenue Per Employee227.55K
Profits Per Employee-21.74K
Employee Count1,139
Asset Turnover0.46
Inventory Turnover2.01
Valuation Ratios
The current PE Ratio of Organigram Global is 2.7. Organigram Global’s PEG ratio is 0.25.
PE Ratio2.7
PS Ratio1.39
PB Ratio1.03
Price to Fair Value1.03
Price to FCF-14.61
Price to Operating Cash Flow-8.27
PEG Ratio0.25
Income Statement
In the last 12 months, Organigram Global had revenue of 259.18M and earned -24.76M in profits. Earnings per share was -0.19.
Revenue259.18M
Gross Profit9.51M
Operating Income-88.31M
Pretax Income-38.53M
Net Income-24.76M
EBITDA-20.55M
Earnings Per Share (EPS)-0.19
Cash Flow
In the last 12 months, operating cash flow was -27.93M and capital expenditures -1.13M, giving a free cash flow of -29.06M billion.
Operating Cash Flow-27.93M
Free Cash Flow-29.06M
Free Cash Flow per Share-0.21
Dividends & Yields
Organigram Global pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.07
52-Week Price Change-21.88%
50-Day Moving Average1.02
200-Day Moving Average1.35
Relative Strength Index (RSI)67.49
Average Volume (3m)484.44K
Important Dates
Organigram Global upcoming earnings date is Dec 22, 2026, TBA (Confirmed).
Last Earnings DateAug 11, 2026
Next Earnings DateDec 22, 2026
Ex-Dividend Date―
Financial Position
Organigram Global as a current ratio of 2.26, with Debt / Equity ratio of 6.48%
Current Ratio2.26
Quick Ratio1.28
Debt to Market Cap<0.01
Net Debt to EBITDA3.64
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Organigram Global has paid -13.77M in taxes.
Income Tax-13.77M
Effective Tax Rate0.36
Enterprise Valuation
Organigram Global EV to EBITDA ratio is -13.88, with an EV/FCF ratio of -11.57.
EV to Sales1.10
EV to EBITDA-13.88
EV to Free Cash Flow-11.57
EV to Operating Cash Flow-37.57
Balance Sheet
Organigram Global has $11.67M in cash and marketable securities with $31.45M in debt, giving a net cash position of -$19.79M billion.
Cash & Marketable Securities$11.67M
Total Debt$31.45M
Net Cash-$19.79M
Net Cash Per Share-$0.14
Tangible Book Value Per Share$1.94
Margins
Gross margin is -5.67%, with operating margin of -34.07%, and net profit margin of -9.55%.
Gross Margin-5.67%
Operating Margin-34.07%
Pretax Margin-14.87%
Net Profit Margin-9.55%
EBITDA Margin-7.93%
EBIT Margin-14.87%
Analyst Forecast
The average price target for Organigram Global is $2.25, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$2.25
Price Target Upside142.33% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast39.67%
EPS Growth Forecast3137.32%